首页> 外文OA文献 >Substance Abuse Treatment: what do we know? An Economist's perspective
【2h】

Substance Abuse Treatment: what do we know? An Economist's perspective

机译:物质滥用治疗:我们知道什么?经济学家的观点

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The literature on treating substance abusehas dealt basically with four important questions:(a) Is treatment effective? (b) Are allprograms equally effective? (c) Why do programs differ in their effectiveness? (d) Which treatments are more cost-effective? This paper reviews the substance abuse treatment literature around these four questions and discusses methodological issues that hinder the interpretation and generalization of results to date. The answer to the first questionis a sounding “yes,” treatment is effectivebut not all programs are equally effective.Researchers have moved beyond the“black box” literature that concentrated onpatient and program characteristics as explanations for differences in effectiveness and search for the “active” ingredients of treatment.These include, for example, the treatmentphilosophy of the program’s directorand staff attitudes towards patients. Cost-effectiveness studies are less common, and their conclusions are mixed. In general, it is probably safe to say that for the majority of patients, outpatient or shorter programs are more cost-effective.
机译:有关滥用药物治疗的文献主要涉及四个重要问题:(a)治疗有效吗? (b)所有程序是否均有效? (c)为何方案的效力不同? (d)哪种治疗更划算?本文围绕这四个问题回顾了药物滥用治疗文献,并讨论了迄今为止阻碍结果解释和推广的方法论问题。第一个问题的答案是听起来是肯定的,治疗是有效的,但并非所有方案都同样有效。研究人员已经超越了“黑匣子”文献,这些文献集中于患者和方案的特征来解释有效性差异并寻求“积极的”方法。 ”治疗成分。例如,包括项目负责人的治疗哲学和工作人员对患者的态度。成本效益研究较少见,其结论参差不齐。通常,可以肯定地说,对于大多数患者而言,门诊或更短的计划更具成本效益。

著录项

  • 作者

    Machado Matilde P.;

  • 作者单位
  • 年度 2005
  • 总页数
  • 原文格式 PDF
  • 正文语种 {"code":"en","name":"English","id":9}
  • 中图分类

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号